Inclusion Criteria:  • Age between 18 and 99 1-year or more use of continuous DRG therapy as delivered a permanently implanted Abbott PROCLAIM XR Dorsal Root Ganglion Neurostimulator System for chronic back and/or leg pain VAS pain score of 6 or greater Must have been seen for routine follow-up within last 4 months Must have been reprogrammed in standard fashion at least once prior to randomization  Willing and able to complete protocol requirements, including:  Complete health questionnaires and pain scales as specified in the protocol Sign the study-specific informed consent form Complete follow-ups at the designated time periods  Exclusion Criteria:  Significant lead migration, as determined by clinician Other concurrent neuromodulation system in place Corticosteroid injection in previous 30 days prior to enrollment Intermittent dosing and/or failure within last 6m Changing or unstable pain medications within 30 days